This factor did not reach statistical significance in multivariate analysis, nevertheless, patients older than 53 years treated with PC/PAC had the worst survival rate.
← all excerpts
TP53 status and taxane-platinum versus platinum-based therapy in ovarian cancer patients: a non-randomized retrospective study.
1
—
—